Is Breast Implant-Associated Anaplastic Large Cell Lymphoma Better Classified as a Lymphoproliferative Disorder and How Surgeons Reduce Risk?
| Autor: | Lukavsky RJ; Community Health Network, 8040 Clearvista Drive, Indianapolis, IN 46256 USA., Couto RA; Couto Plastic Surgery, 59 Calle Kings Court, #702, San Juan 00911, Puerto Rico., Adams WP Jr; UT Southwestern Aesthetic Surgery Fellowship, UT Southwestern Department of Plastic Surgery, 6901 Snider Plaza, Suite 120, Dallas, TX 75205, USA. Electronic address: dr@dr-adams.com. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Clinics in plastic surgery [Clin Plast Surg] 2021 Jan; Vol. 48 (1), pp. 71-77. Date of Electronic Publication: 2020 Oct 09. |
| DOI: | 10.1016/j.cps.2020.08.002 |
| Abstrakt: | Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a complex topic with evolving classification and etiology. Commonalities between BIA-ALCL and lymphoproliferative disorders exist, suggesting that BIA-ALCL may be better represented on a spectrum of disease from benign effusion to malignant metastatic lymphoma. Meticulous sterile surgical technique, involving the use of betadine-containing irrigation, should be used to decrease the biological burden introduced into the surgical field and possibly prevent future incidences of BIA-ALCL. Competing Interests: Conflict of interest/funding None of the authors have any conflict of interest with the study or its findings, and no funding was received for the study. (Copyright © 2020 Elsevier Inc. All rights reserved.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|